ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: interstitial lung disease

Clinical Cutting Edge

Jane Jerrard  |  July 1, 2007

Updates on Sjogren’s syndrome, myositis, and vasculitis

Filed under:ConditionsMyositisSjögren’s DiseaseVasculitis Tagged with:Diagnostic CriteriaMeetingmyositisSjogren'sTreatmentVasculitis

Reading Rhuem

Robyn T. Domsic, MD; Gail C. Davis, RN, EdD; Mary Corr,MD  |  February 1, 2007

Handpicked Reviews of Contemporary Literature

Filed under:ConditionsMyositisResearch Rheum Tagged with:myositisOsteoarthritisprognosisReading RheumResearchRheumatoid arthritis

Labored Breathing

Staff  |  January 1, 2007

Strategies to diagnose and manage dyspnea in the scleroderma patient

Filed under:ConditionsSystemic Sclerosis Tagged with:DiagnosisInterstitial Lung DiseaseManagementpulmonary arterial hypertensionSclerodermaSystemic sclerosisTreatment

Trimethoprim Sulfamethoxazole Prophylaxis & Infections in Patients with GPA

Arthritis & Rheumatology  |  December 1, 2023

SAN DIEGO—In their study, Effect of Trimethoprim Sulfamethoxazole Prophylaxis on Infections During Treatment of Granulomatosis with Polyangiitis with Rituximab: A Population-Based Study, Mendel et al. assessed the relationship between trimethoprim sulfamethoxazole (TMP-SMX) and infection in patients undergoing treatment for granulomatosis with polyangiitis (GPA). Background/Purpose Infections during treatment of anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis (AAV)…

Filed under:ACR ConvergenceConditionsMeeting ReportsVasculitis Tagged with:AAVAAV FocusRheumACR Convergence 2023Arthritis & Rheumatologygranulamatosis with polyangiitisResearch

Research Helps Explain Idiosyncrasies of COVID-19

Jason Liebowitz, MD, FACR  |  November 23, 2021

The Basic and Clinical Research Conference session on Rheumatology Complications of Emerging Viral Infections/SARS-CoV-2 presented findings from numerous studies that help explain some of the idiosyncrasies of COVID-19.

Filed under:ACR ConvergenceConditionsMeeting ReportsPediatric Conditions Tagged with:ACR Convergence 2021COVID-19interferonMultisystem Inflammatory Syndrome in Children (MIS-C)

Pulmonary Adverse Events with Low-Dose Methotrexate

Arthritis & Rheumatology  |  November 24, 2020

In this large placebo-controlled trial, Sparks et al. examined the predictors and severity of pulmonary adverse events (AEs) in patients taking low-dose MTX. The researchers found that low-dose MTX increased the risk of pulmonary AEs, including possible pneumonitis.

Filed under:ConditionsDrug UpdatesResearch Rheum Tagged with:Arthritis & RheumatologyResearch

Systemic Sclerosis Patients May Benefit from Targeted Stroke Screening

Lara C. Pullen, PhD  |  April 27, 2020

Patients with systemic sclerosis (SSc) may benefit from targeted stroke screening or prevention therapies. A recent study revealed SSc may be independently associated with stroke, finding the risk of stroke was 20–30% higher in SSc patients than healthy controls…

Filed under:ConditionsOther Rheumatic Conditions Tagged with:brainriskstrokeSystemic sclerosissystemic sclerosis (SSc)

Case Report: Possible Overlapping Vasculitis & Ulcerative Colitis

Julia Jing-ou Tan, MD, Mohammad Bardi, MD, & Natasha Dehghan, MD  |  January 17, 2020

A 42-year-old man with a history of ulcerative colitis (UC), primary sclerosing cholangitis (PSC) and chronic sinusitis was referred to a rheumatologist to evaluate for a possible diagnosis of systemic vasculitis. This patient had developed new skin lesions, gingival hypertrophy and ulcerating tracheobronchitis, concerning for possible granulomatosis with polyangiitis (GPA). Since 1994, the patient had…

Filed under:ConditionsVasculitis Tagged with:case reportulcerative colitis

A Case Study in Sweet’s Syndrome with Pulmonary Involvement

Lara C. Pullen, PhD  |  March 19, 2019

CHICAGO—Physicians from the University of Chicago presented an intriguing case of Sweet’s syndrome for the Clinical Pathological Conference during the 2018 ACR/ARHP Annual Meeting. Pankti Reid, MD, MPH, a rheumatology fellow at the University of Chicago, introduced the case of a white man who, in 2017, came under the care of the University of Chicago….

Filed under:ConditionsMeeting Reports Tagged with:2018 ACR/ARHP Annual MeetingSweet's syndrome

Rheumatology Case Report: TINU Syndrome with Concomitant Synovitis

Ambreesh Chawla, MD, David Benderson, MD, Mikhail Kotlov, MD, Evan Leibowitz, MD, & Ashraf Raslan, MD  |  November 10, 2017

Tubulointerstitial nephritis and uveitis (TINU) syndrome, also known as Dobrin syndrome, is a rare oculo-renal inflammatory disease. It was first described in 1975 by American physician Robert Dobrin, MD.1 It manifests as acute interstitial nephritis and bilateral uveitis. In addition, patients often experience nonspecific systemic findings, such as fever, weight loss, malaise, myalgia and arthralgia. TINU…

Filed under:ConditionsOther Rheumatic ConditionsResearch Rheum Tagged with:case reportClinicalDiagnosisDobrin syndromeeyehandocularoculo-renal inflammatory syndromeophthalmologyoutcomepatient careRenalResearchrheumatologystudysyndromesynovitisT-lymphocytesTINUtubulointerstitial nephritis and uveitis

  • « Previous Page
  • 1
  • …
  • 24
  • 25
  • 26
  • 27
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences